Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -35.99-579.49-62.36150.21-353.26

What is the latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL is -35.99 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-35.99
Mar2023-579.49
Mar2022-62.36
Mar2021150.21
Mar2020-353.26

How is Core EBITDA Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Growth % Change
Mar2024 -35.99
Negative
Mar2023 -579.49
Negative
Mar2022 -62.36
Negative
Mar2021 150.21
Positive
Mar2020 -353.26 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹255.2 Cr -1.5% -3.8% 7.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,063.0 Cr 3% 3.5% -15.1% Stock Analytics
DIVIS LABORATORIES ₹155,749.0 Cr 3.1% -4.8% 4.9% Stock Analytics
CIPLA ₹122,429.0 Cr 1.1% -4% -8.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,928.0 Cr -1.4% -2.6% 4.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,168.0 Cr -0.4% -1.1% -7.8% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-1.5%

-3.8%

7.4%

SENSEX

0.1%

1.3%

-5.1%


You may also like the below Video Courses